Mandate

Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier

May 22, 2019 M&A

Vinge has advised the global investment company, KKR in connection with the acquisition by its portfolio company Crosby of Gunnebo Industrier from Segulah and minority investors.

Crosby is a global, market‑leading company with products within lifting and rigging. Gunnebo Industrier is an international manufacturing group that provides lifting and material handling products to a global customer base. The company was founded in 1764 and has manufacturing units in Sweden, Norway and the USA with subsidiaries in nine countries and distribution partners in more than 50 countries.

Vinge’s team consisted of, among others, Christina Kokko, Samra Baytar, Marith Welin-Berger and Hanna Risberg (Corporate and M&A), Adriana Berglund and Michael Montner (Commercial Agreements), Lisa Ullman (Employment), André Isacson and Josefine Larsson (Banking and Finance), Klara Secher and Hannah Kajlinger (IP), Kristoffer Larson (Real Property), Agnes Perbo and Nicklas Thorgerzon (IT) and Jessica Öijer (VDR assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025